Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

news

InnoSIGN appoints Eric Lindquist new Chief Executive Officer

events

Identifying mutation-independent signaling pathway activation in molecular subtypes of triple negative breast cancers

events

Racial differences in estrogen receptor signaling pathway activity in breast cancer patients